Arena Pharmaceuticals

Type	Public (NASDAQ: ARNA)
Headquarters	San Diego, California, USA
Key people	Jack Lief, cofounder and CEO Dominic Behan, co-founder and senior scientist
Industry	Biotechnology
Products	in development
Website	www.arenapharm.com

Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. Currently none of the drugs is approved by the U.S. Food and Drug Administration, but several are in Phase I to III testing, namely (stand January 2009):

• Lorcaserin, Phase III , indication: obesity.
• APD791, Phase I, indication: arterial thrombosis.
• APD916, entering Phase I, indication: pulmonary hypertension.
• Niacin receptor antagonist, Phase I, indication: arteriosclerosis, (in conjunction with Merck)
• ADP597, Phase II, indication: diabetes type 2, (in conjunction with Ortho-McNeil-Janssen)

[edit] See also

• List of biotechnology companies

[edit] External links

• Official web site

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. v • d • e